483866498
31 Jan 2023
China The State Food and Drug Administration conditionally approved the combination packaging of the new coronavirus infection treatment drug prenortevir tablets ritonavir tablets and deuterium remidevir hydrobromide tablets for marketing, China
Severity: Notice
Message: Undefined variable: region
Filename: views/login_detail_view_new_V1.php
Line Number: 393
Procurement News
Click for more details
If you have forgotten your User ID or Password, then please contact the TendersInfo Customercare by Email on customercare@tendersinfo.com.